IMS Health (IMS) Tops Q1 EPS by 4c

IMS Health (NYSE: IMS) reported Q1 EPS of $0.42, $0.04 better than the analyst estimate of $0.38. Revenue for the quarter came in at $774 million versus the consensus estimate of $749.34 million.

IMS Health is providing second-quarter constant currency guidance as follows: Revenue growth of 7.5 to 8.5 percent, Adjusted EBITDA growth of 5 to 6 percent, Adjusted Net Income growth of 4.5 to 5.5 percent and Adjusted Diluted Earnings per Share growth of 5.5 to 6.5 percent.

For earnings history and earnings-related data on IMS Health (IMS) click here.

You May Also Be Interested In

• SAP Q1 results fall short of Wall Street estimates as transformation kicks off
• Cleveland-Cliffs (CLF) Misses Q1 EPS by 4c
• SmartFinancial (SMBK) Tops Q1 EPS by 8c